TABLE 1.
Characteristics of mecC- and/or mecA-positive MRSA isolates from dairy sheep farms, Spain, 2008–2009
| Resistance determinant | Farm code (no. of isolatesa) | Date of isolation (mo/day/yr) | Region | MLST | SCCmec | MRSA clone | Antibiotic resistanceb |
|---|---|---|---|---|---|---|---|
| mecC | 648 (1) | 3/03/2009 | Zamora | ST130 | XI | ST130-MRSA-XI | β-Lactams only |
| mecA | 741 (3) | 4/07/2009 | Palencia | ST398 | V | ST398-MRSA-V | β-Lactams, Tet |
| mecA | 1040 (3) | 7/28/2009 | Palencia | ST398 | IVa | ST398-MRSA-IV | β-Lactams, Tet |
| mecA | 1043 (3) | 7/28/2009 | Valladolid | ST398 | V | ST398-MRSA-V | β-Lactams, Tet |
a
Three isolates from each farm were analyzed.
b
The antibiotic panel included penicillin, oxacillin, amoxicillin-clavulanate, daptomycin, cefazolin, erythromycin, clindamycin, teicoplanin, vancomycin, ciprofloxacin, levofloxacin, amikacin, gentamicin, tobramycin, mupirocin, rifampin, tetracycline (Tet), fusidic acid, fosfomycin, nitrofurantoin, linezolid and co-trimoxazole.